References

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Laboratory Effectiveness: Clinical Laboratory Utilization (retired 6/6/2018). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Laboratory Effectiveness: Clinical Laboratory Utilization (retired 6/6/2018) (online CE course)
References

Baird GS, Rainey PM, Wener M, Chandler W. Reducing routine ionized calcium measurement. Clin Chem. 2009;55(3):533-540.
Guerry SL, Bauer HM, Packel L, et al. Chlamydia screening and management practices of primary care physicians and nurse practitioners in California. J Gen Intern Med:2005;20(12).
Howanitz PJ, Steindel SJ. Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels. Arch Pathol Lab Med: 1993;117(7):684–90.
Improving laboratory test utilization through physician report cards with feedback from leadership: an interview with Kim Riddell, MD. Laboratory Errors and Patient Safety: 2006;2(4).
Levenson D. Which tests should be considered obsolete? Clin Lab News, December 2007:33(12).
Our skyrocketing health care costs, in one chart. The Washington Post. Taken from OECD Health Data, June 2011
Qureshi AI, Suri FK, Guterman LR, et al. Ineffective secondary prevention in survivors of cardiovascular events in the US population. Arch Intern Med: 2001;161:1621–1628.
United Health Center for Health Reform & Modernization/Harris Interactive survey of consumers. January 2012.
Valenstein PN, Walsh MK, Meier F, et al. Heparin monitoring and patient safety: a College of American Pathologists Q-Probes study of 3431 patients at 140 institutions. Arch Pathol Lab Med: 2004;128:397–402.